Timing explainer
Is It Too Late for Hormone Therapy? Timing Explainer
Guidelines describe a timing window: for most healthy women with bothersome symptoms, hormone therapy started before 60, or within 10 years of the last period, carries the most favorable balance of benefits and risks. Answer a few questions to see where you sit, which parts of your history matter, and the questions to bring to your doctor.
Reviewed October 24, 2026 · Free to use · Your answers stay on this device
- Under 60or within 10 years of menopause
- Any agefor low-dose vaginal estrogen
- 5history questions that change the answer
- 2 minutesto complete
Where the Timing Window Comes From
Early reports from the Women's Health Initiative in 2002 led many women to stop hormone therapy. Later analyses showed that age and time since menopause changed the picture.
- 2002The Women's Health Initiative reports higher breast cancer and heart risks in a study group with an average age of 63.
- 2007 to 2017Reanalyses by age group find lower risks and fewer heart events in women who start within 10 years of menopause.
- 2022The Menopause Society position statement describes the window: favorable under 60 or within 10 years, less favorable after.
- 2026The FDA approves the first labels without the heart, breast cancer and dementia boxed warning statements, and ACOG publishes Clinical Practice Guideline No. 13 on menopause symptoms.
Timing Is One Part of the Decision
Dose, form and route change the risk picture as much as age. Estrogen through the skin, for example, carries a lower blood clot risk than estrogen by mouth in observational studies.
Dr. Samia McCully, ND reviews history, labs and symptoms before recommending any hormones, and works with your other doctors when a case calls for it. The bioidentical hormone therapy guide covers the options in detail.
Common Questions
Is hormone therapy off the table after 60?
Not automatically. The Menopause Society's 2022 position statement says the benefit-risk balance becomes less favorable when therapy starts after 60 or more than 10 years after menopause, and it supports individualized decisions about dose, type and route. Continuing therapy past 65 is also an individual decision rather than a hard stop.
Does the timing window apply to vaginal estrogen?
Low-dose vaginal estrogen for dryness, painful sex and urinary symptoms has very low absorption into the bloodstream. Guidelines support it at any age for those symptoms, including for many women who are not candidates for systemic therapy.
What changed with the 2026 FDA labeling?
In November 2025 the FDA asked makers of menopausal hormone therapy to remove the boxed warning statements on heart disease, breast cancer and probable dementia, and in February 2026 it approved the first six updated labels. The warning about endometrial cancer with estrogen used alone in women who have a uterus remains.
Why does having a uterus matter?
Estrogen alone thickens the uterine lining and raises the risk of endometrial cancer. Women with a uterus who use systemic estrogen also take a progestogen, such as progesterone, to protect the lining.
Sources and How This Tool Works
The timing logic follows The Menopause Society's 2022 hormone therapy position statement: for women under 60 or within 10 years of menopause without contraindications, the benefit-risk ratio is favorable for bothersome vasomotor symptoms and bone loss prevention; for women who start later it is less favorable. Low-dose vaginal estrogen is treated separately, as the statement does. The history questions reflect standard contraindications listed in ACOG guidance and FDA labeling. The result describes where guidelines place you; it does not decide whether hormone therapy is right for you. Everything runs in your browser.
- The Menopause Society. The 2022 hormone therapy position statement. Menopause, 2022
- American College of Obstetricians and Gynecologists. Clinical Practice Guideline No. 13, October 2026
- Patient Care. FDA removes boxed warnings on cardiovascular, cancer and dementia risks from select menopausal hormone therapy labels, February 2026
General health information, reviewed October 24, 2026. This tool informs; it does not diagnose, treat or replace care from a licensed clinician, and the linked sources' current versions control. Any vaginal bleeding after menopause needs an evaluation before hormone therapy starts. If something feels urgent, call 911 or your doctor.
Wondering whether hormone therapy fits you? Start with a free discovery call.
Book a Discovery Call